FREEDOM BLOG

ADDICTION & RECOVERY

The Value of Desperation

By Bob Miller January 19, 2018

Since 2012, Bob Miller has been Chairman of the Board, Freedom Institute, the non-profit recovery center founded by his mother in 1976.  Under his leadership, Freedom Institute has kept pace with the newest modalities in evidence-based treatment and the changing landscape of substance abuse prevention and recovery to become one of the leading non-profit, out-patient […]

Read More
ADDICTION & RECOVERY

Multi-Family Therapy Group

By editor10022 December 19, 2017

As part of our existing morning intensive outpatient program (MIOP) for adults, Freedom Institute has introduced a multi-family therapy group which meets once during each MIOP (8-week) cycle. Our supportive approach aims to help families relate to others who also are struggling with the impact of substance abuse on the family system. Our goal is […]

Read More
ADDICTION & RECOVERY

A GUIDE THROUGH THE MINEFIELD OF FINDING RESIDENTIAL TREATMENT

By Peter Lazar November 29, 2017

by Peter Lazar, LCSW Peter Lazar, LCSW, is Freedom Institute’s Senior Director of Strategic Development.  As part of the leadership team at Freedom Institute, Peter is responsible for overseeing marketing, business development and customer relations, as well as contributing to strategy and organizational development. In the shifting sands of the addictions treatment world, it has […]

Read More
Families in Recovery

Teaching Empathy through Psychodrama: A Q&A with Anne Bresnahan, CASAC-G, Adult Counselor

By Anne Bresnahan October 23, 2017

Anne Bresnahan has worked in the field of addiction with both adults and adolescents for over 20 years. She joined Freedom Institute as an Adult Counselor in 2013 to lead our Psychodrama Program. Anne brings her love for and training in Psychodrama, Sociometry and Group Psychotherapy to her role and utilizes Motivational Interviewing, CBT and […]

Read More
ADDICTION & RECOVERY

Big Pharma, Doctors, Insurers…Are They All to Blame?

By Andree Corroon September 19, 2017

Drug companies and doctors have been accused of fueling the opioid crisis, but some question whether insurers have played a role, too. The New York Times investigates how amid an opioid crisis, insurers are restricting pricey, less addictive painkillers. At a time when the United States is in the grip of an opioid epidemic, many insurers are […]

Read More